Charles River

© GettyImages/Dr_Microbe

Charles River looks to speed up viral vector manufacturing

By Jane Byrne

Charles River Laboratories International has launched a new AAV based platform that it claims has the capability to reduce time from process development to GMP by 55% and deliver a drug product in fewer than eight months.